These studies confirm and extend previous studies and demonstrate the ability of a patient's lung-tumor derived CTLs to specifically home to a orthotopically grown xenograft composed of the autologous tumor cells, suppress tumor growth and express IFN-γ in vivo without the administration of exogenous human cytokines. This evidence concerns the gene IFNG and neoplasm.